We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWO
3651
Two Harbors Investment
TWO
$1.26B
$166K ﹤0.01%
12,536
-100
-0.8% -$1.27K
MUC icon
3652
BlackRock MuniHoldings California Quality Fund
MUC
$1.01B
$164K ﹤0.01%
14,736
-4,466
-23% -$48.5K
UAA icon
3653
Under Armour
UAA
$2.31B
$163K ﹤0.01%
24,390
-14,487
-37% -$98.8K
GERN icon
3654
Geron
GERN
$1.03B
$162K ﹤0.01%
38,315
+715
+2% +$2.79K
GRX
3655
Gabelli Healthcare & Wellness Trust
GRX
$147M
$162K ﹤0.01%
16,944
+10
+0.1% +$96
VLRS
3656
Controladora Vuela Compania de Aviacion
VLRS
$910M
$157K ﹤0.01%
+24,742
New +$190K
EFC
3657
Ellington Financial
EFC
$1.74B
$154K ﹤0.01%
12,767
-807
-6% -$9.51K
BTA
3658
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
$152K ﹤0.01%
14,994
+13
+0.1% +$130
QIPT
3659
DELISTED
Quipt Home Medical
QIPT
$151K ﹤0.01%
47,000
PCT icon
3660
PureCycle Technologies
PCT
$1.52B
$151K ﹤0.01%
25,512
-35,021
-58% -$190K
CRBU icon
3661
Caribou Biosciences
CRBU
$168M
$151K ﹤0.01%
92,073
-9,078
-9% -$29K
NVDA icon
3662
PUT
NVIDIA
NVDA
$5.28T
$151K ﹤0.01%
1,300
-19,700
-94% -$1.99M
PACB icon
3663
Pacific Biosciences
PACB
$361M
$150K ﹤0.01%
109,767
+23,161
+27% +$46.8K
ARDX icon
3664
Ardelyx
ARDX
$982M
$150K ﹤0.01%
20,211
+142
+0.7% +$998
BRDG
3665
DELISTED
Bridge Investment Group
BRDG
$150K ﹤0.01%
20,156
-3,598
-15% -$25.8K
VRDN icon
3666
Viridian Therapeutics
VRDN
$2.61B
$149K ﹤0.01%
11,440
-109
-0.9% -$1.51K
NRO
3667
Neuberger Real Estate Securities Income Fund Inc
NRO
$187M
$148K ﹤0.01%
46,133
+501
+1% +$1.54K
ALT icon
3668
Altimmune
ALT
$583M
$146K ﹤0.01%
21,991
-99,146
-82% -$732K
HYB
3669
DELISTED
New America High Income Fund, Inc.
HYB
$144K ﹤0.01%
19,655
+2,012
+11% +$14.5K
ZYME icon
3670
Zymeworks
ZYME
$1.73B
$144K ﹤0.01%
16,882
-11,405
-40% -$102K
UUUU icon
3671
Energy Fuels
UUUU
$3.66B
$144K ﹤0.01%
23,682
+10,000
+73% +$61.1K
CBUS icon
3672
Cibus
CBUS
$147M
$142K ﹤0.01%
14,448
+500
+4% +$7.55K
CGEN icon
3673
Compugen
CGEN
$227M
$142K ﹤0.01%
84,625
-2,200
-3% -$4.58K
RPT
3674
Rithm Property Trust
RPT
$98.2M
$141K ﹤0.01%
6,596
-5,484
-45% -$117K
EVF
3675
Eaton Vance Senior Income Trust
EVF
$91.8M
$141K ﹤0.01%
22,242
-12,765
-36% -$81.5K

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.